Related Experiment Video
Updated: May 29, 2026

Preparation of Human Tissues Embedded in Optimal Cutting Temperature Compound for Mass Spectrometry Analysis
Published on: April 27, 2021
Inhibitors of specific ceramide synthases
Susanne Schiffmann1, Daniela Hartmann, Sina Fuchs
1Pharmazentrum Frankfurt/ZAFES, Institute of Clinical Pharmacology, Goethe-University Frankfurt, Theodor-Stern-Kai 7, 60590 Frankfurt/Main, Germany.
Researchers identified novel inhibitors targeting ceramide synthases (CerSs), crucial enzymes in ceramide production. These compounds, derived from Fingolimod, show potential for developing new cancer therapies by selectively blocking specific CerS enzymes.
Area of Science:
- Biochemistry
- Molecular Biology
- Pharmacology
Background:
- Ceramide synthases (CerSs) are essential enzymes for synthesizing ceramides, bioactive lipids with diverse cellular roles.
- Different ceramide N-acyl side chains (C14:0-C26:0) mediate distinct cell signaling pathways.
- Selective CerS inhibition offers therapeutic potential, particularly in cancer treatment.
Purpose of the Study:
- To identify and characterize novel functional inhibitors of ceramide synthases.
- To evaluate the inhibitory effects of FTY720-derived compounds on specific CerS isoenzymes.
- To explore the structure-activity relationships and biological impact of these inhibitors.
Main Methods:
- In vitro ceramide synthase activity assays were employed to determine inhibitory effectiveness.
- Two human cell lines (HCT-116 and HeLa) with distinct ceramide profiles were used for testing.
- Structure-activity relationships were analyzed for the identified inhibitors.
Main Results:
- Four novel functional CerS inhibitors were identified from the FTY720 lead structure.
- ST1058 and ST1074 preferentially inhibited CerS2 and CerS4.
- ST1072 potently inhibited CerS4 and CerS6, while ST1060 predominantly inhibited CerS2.
Conclusions:
- The identified compounds demonstrate selective inhibition of specific CerS isoenzymes.
- These novel inhibitors hold promise for targeted therapeutic strategies, especially in oncology.
- Further investigation into structure-activity relationships can guide the development of more potent and selective CerS inhibitors.
More Related Videos
Related Concept Videos
Inhibitors of Viral Protein Synthesis
Inhibition of Cdk Activity
Inhibition of CDK Activity
Inhibitors of Gram-positive Cell Wall Synthesis
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
Inhibitors of Virion Maturation and Assembly

